🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to see Rapid Progressive Dementia on the main stage at this year’s #AANAM! Expertly presented by Dr. R van Steenhoven, with discussant Stacey Clardy MD PhD. American Academy of Neurology

University of Utah Neurology Residents! Sylvia Eshun🧠⚕️🩺 Team Ghana! 🇬🇭🇬🇭 #AANAM

We're incredibly proud of Dr. Trout for presenting on #NMDARencephalitis at the BYU Neuroscience Symposium! It’s inspiring to see the impactful work being done in autoimmune neurology.

Grateful for an inspiring week at #AAN2025 with our amazing team. From residents to faculty, every moment reminded us why we love what we do. Until next year! 🧠 U of U Neurology Residency #Neurofamily #UofUHealth #AAN

Being involved in the @ExTINGUISHTrial for NMDAR Encephalitis is the honor - and challenge - of a lifetime. And our community is making it a reality ❤️ Fantastic updates: 📣 As of 2025 ALL 37 US and 2 EU ExTINGUISH Trial sites are enrolling patients with NMDAR Encephalitis 1/

📣 We are able to offer the trial to affected adolescents and adults — new NMDAR Encephalitis patients age 12 and up have access to the Trial resources 🤝 📣 No matter where in the US, we will get new NMDAR encephalitis patients access to the trial - just call 844-4BRAIN5 2/

Thank you, Dr. Wesley Sundquist, for helping us celebrate our University of Utah Neurology Department Research Day at the Baringer Symposium 🧠🦠

Just published 👉 A NEWLY updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote 🧠🔥 Why is this paper so important ? 1/

Link to article here: jni-journal.com/article/S0165-… Link to ExTINGUISH Trial info here: neuronext.org/projects/nn111…

Neurology Podcast: Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with #epilepsy or seizures. Listen now: hubs.la/Q03rwS2Q0 #NeuroTwitter

Never underestimate the importance of arranging a timely outpatient followup visit - with Neurology and/or Primary Care 🤝🫶

We’re thrilled to celebrate our graduating neurology residents! 🎓🧠 We’re incredibly proud of the talent, heart, and hard work each of them brings to the field. Congratulations, Class of 2025! U of U Neurology Residency #Neurology #ResidencyGraduation

Now enrolling patients across the US and Europe, the phase 2b ExTINGUISH trial is a multicenter study evaluating 300-mg inebilizumab for moderate-to-severe #NMDAR encephalitis. Led by Stacey Clardy MD PhD, MD, PhD, FAAN, of @UfUNeurology, the newly published trial design outlines a

We’re excited to welcome our new PGY-1s! 🧠 This talented group is kicking off their journey, and we’re thrilled to have them on board. U of U Neurology Residency #UofUNeuro #PGY1 #Neurology

📣 Saturday August 16 is for PATIENTS, designed by PATIENTS, for free, on what is most helpful in autoimmune neurologic conditions: -Navigating insurance + finances -Partnering with primary care -Symptom management -Getting outside to play, adaptively -Updates/Tips from experts

Utah leads the nation in stroke response times—the only state where 85%+ of patients receive treatment within 45 mins of hospital arrival. Proud of University of Utah Health and statewide partners for driving this progress. Special thanks to Drs. Jenny Majersik, Christy Hopkins, Stefan Pulst,

Curious about Neurology residency? Join Ligia Onofrei, MD, Program Director of the University of Utah Neurology Residency, for a Virtual Open House! U of U Neurology Residency 📅 Aug 7 @ 5 pm & Aug 13 @ 7 pm (MT) 📧 Register: [email protected] #NeurologyResidency #UofUNeurology

August 16 | Salt Lake City Join us for a #PatientDay focused on NMOSD, MOGAD, AE, SPS & more. The Sumaira Foundation 🧠 Ask experts, connect with others, & build community. Register by 8/13: tinyurl.com/TSFSLC #Neuroimmune

🧠 Join us for the 64th WINO Conference on Friday October 24 2025! We’re also celebrating 60 years of the University of Utah Department of Neurology with a special dinner! Register Here: bit.ly/4aSgBPh

The ExTINGUISH Trial Methods Paper is available, Open Access! 👉There are no approved (or rigorously studied) treatments for NMDAR Encephalitis. 👉 Enrollment is ongoing for newly diagnosed NMDAR Encephalitis patients, via NIH/NINDS & the NeuroNEXT Clinical Trial Network